According to Calithera Biosciences
's latest financial reports the company has a price-to-book ratio of 0.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2022-12-31 | 0.7778 | -86.92% |
2021-12-31 | 5.95 | 75.7% |
2020-12-31 | 3.38 | 32.9% |
2019-12-31 | 2.55 | 107.2% |
2018-12-31 | 1.23 | -37.64% |
2017-12-31 | 1.97 | 45.93% |
2016-12-31 | 1.35 | -30.58% |
2015-12-31 | 1.95 | -46.13% |
2014-12-31 | 3.61 | |
2013-12-31 | N/A |